The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature

Withdrawn before enrolling · Not applicable

Conditions studied: Short Stature

In brief

The purpose of the study is to evaluate the predictive value of IGF-1 generation test for growth velocity during GH treatment for 12 months.

Key facts

Study ID

NCT01970800

Run by

Maimonides Medical Center

People needed

0

Starts

2013-01-01

Expected to finish

2014-12-01

Last updated by the study team

2018-08-17

Who can join

Age: 5 and older, up to 11. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ability to provide written informed consent
• Prepubertal males and females form 5- 11years old
• Bone age <11 years in males and <9 years in females
• Height SD score<-2.25SD in males and females
• IGF-1SD score <-1SD in both males and females
• Peak GH level after stimulation >10ng/ml

You may not qualify if…

• History of prior chemotherapy and or radiation
• Active neoplasm
• Pediatric patients with closed epiphyses
• Prader-Willi syndrome, Turner syndrome or any other genetic or chromosomal anomaly
• Treatment with inhaled or systemic steroids
• BMI <5th percentile or >95th percentile
• Tanner 2 at clinical or biochemical examination by ultrasensitive LH and FSH

Where it is running

• Maimonides Medical Center — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.